Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response.

Source:http://linkedlifedata.com/resource/pubmed/id/19289516

Download in:

View as

General Info

PMID
19289516